We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong’s PCR Lab Solution Safeguards 2022 G20 Indonesia Summit

By LabMedica International staff writers
Posted on 03 Jan 2023
Print article
Image: Tianlong`s PCR lab solution provided protection at the G20 summit in 2022 in Indonesia (Photo courtesy of Tianlong)
Image: Tianlong`s PCR lab solution provided protection at the G20 summit in 2022 in Indonesia (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China) safeguarded a successful G20 summit in 2022 in Indonesia, which has been one of the company’s largest overseas markets. Before the G20 summit, Tianlong's PCR lab solution was applied in several healthcare centers locally, including the Jakarta international airport. The company’s solution helps conduct nucleic acid testing for inbound and outbound passengers, and protected the gateway to Indonesia during the COVID-19 phase.

Tianlong’s star products – the Gentier 96 Real-Time PCR system and Libex nucleic acid extractor – have received high praise from clients in Indonesia due to their high efficiency and stable quality. The Gentier 96E/96R real-time fluorescence quantitative PCR detection system is tailored to meet the needs of high-end users. The product has many advantages, such as a scientific and efficient temperature control system and photoelectric system, powerful and easy-to-use software analysis function, humanized control mode, etc., and can easily realize the application of downstream multiple gene detection, quantitative analysis, SNP analysis, fusion curve analysis and so on. It is widely used in medical institutions, universities and research institutes, CDC, exit inspection and Quarantine Bureau, public security criminal investigation and material evidence identification center, veterinary station, food enterprises and dairy products factories.

Tianlong’s Libex nucleic acid extractor, which is based on the automated extraction method of magnetic bead adsorption separation, overcomes the shortcomings of conventional nucleic acid extraction methods and achieve rapid and efficient sample preparation. With the appropriate nucleic acid extraction reagents, it can process serum, plasma, whole blood, swabs, amniotic fluid, feces, tissue and tissue lavage, paraffin sections, bacteria, fungi and other sample types. The Libex nucleic acid extractor is widely used in the fields of disease prevention and control, animal quarantine, clinical diagnosis, entry-exit inspection and quarantine, food and drug administration, forensic medicine, teaching and scientific researches.

Tianlong continues to innovate to make better products and offer better services to its customers worldwide. The company continues to cooperate with its clients and jointly develop better solutions for the global markets.

Related Links:
Tianlong Science and Technology

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.